ATOSSA GENETICS
Atossa Genetics is a health care company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer. Using our patented, FDA-approved Mammary Aspirate Specimen Cytology Test (MASCT) System, a nurse or physician’s assistant, can painlessly collect a sample of Nipple Aspirate Fluid (NAF) in about 10 minutes. The NAF sample contains cells (cytology) and molecular diagnostic biomarkers that are useful in finding cancers and pre-cancerous changes, especially Atypical Ductal Hyperplasia (ADH), which confers a higher risk of developing breast cancer.
ATOSSA GENETICS
Industry:
Biotechnology Genetics Health Care Medical Device
Founded:
2009-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.atossatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(206) 588-0256
Total Funding:
32.6 M USD
Technology used in webpage:
SPF Domain Not Resolving Amazon Google Apps For Business GoDaddy DNS Pound Sterling Japanese Yen Fastly Hosted Fastly Load Balancer Amazon California Region
Similar Organizations
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Aspire Capital Partners LLC
Aspire Capital Partners LLC investment in Post-IPO Equity - Atossa Genetics
Keiretsu Forum Northwest
Keiretsu Forum Northwest investment in Venture Round - Atossa Genetics
Official Site Inspections
http://www.atossatherapeutics.com Semrush global rank: 2.44 M Semrush visits lastest month: 7.37 K
- Host name: 223.54.212.35.bc.googleusercontent.com
- IP address: 35.212.54.223
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
